Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
436. |
ECCT/12/08/01 | Partners Demonstration Project An open-label, pilot demonstration and evaluation project of antiretrovira-based HIV-1 prevention among high-risk HIV-1 serodiscordant African couples. |
Principal Investigator(s) 1. Dr. Nelly Rwamba Mugo Site(s) in Kenya 1. Partners in Prevention, Thika Site (Kiambu county) 2. Partners in Prevention, Kisumu Site (Kisumu county) |
View |
437. |
ECCT/12/07/03 | PK Substudy of A5263 and A5264 A5278 - Pharmacology Substudies of A5263 and A5264 |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Walter Reed Project (Kericho county) |
View |
438. |
ECCT/12/07/01 | MULTI-OCTAVE (Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure) A5288 "Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure" (MULTI-OCTAVE) |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya Moi University Clinical Research Centre |
View |
439. |
ECCT/12/04/03 | SELECT (SEcond-Line Effective Combination Therapy) A5273: Multicenter Study of Options for SEcond-Line Effective Combination Therapy (SELECT) |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya Moi University Clinical Research Centre |
View |
440. |
ECCT/12/04/02 | Short-course RPT/INH for latent TB in HIV-infected individuals A5279: Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) |
View |